Controlled-Release Formulation Design
Formulation design is our core area of expertise. We make custom, long-acting, controlled release formulations of poly(lactic-co-glycolic) acid (PLGA) and other biocompatible materials with extensive track records of FDA approval that deliver drugs or biologics over days, weeks, months or years. These formulations include injectable microparticles, matrix implants and thin-film coatings.
Qrono is transforming the design of long-acting, controlled release formulations from a time consuming, expensive, and risky process based on heuristics and experimentation to a fast, predictable, engineering approach based on predictive modeling with its QronoMetrics™ software.